Maintaining Intestinal Health: The Genetics and Immunology of Very Early Onset Inflammatory Bowel Disease
暂无分享,去创建一个
[1] Ta-Chiang Liu,et al. Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.
[2] M. Farrar,et al. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4+ T cells , 2015, Science.
[3] S. Latour,et al. X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome , 2015, Journal of Clinical Immunology.
[4] S. Latour,et al. XIAP deficiency syndrome in humans. , 2015, Seminars in cell & developmental biology.
[5] S. Pai,et al. Stem cell transplantation for primary immunodeficiency diseases: the North American experience , 2014, Current opinion in allergy and clinical immunology.
[6] Ç. Karaca,et al. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening , 2014, Scandinavian journal of gastroenterology.
[7] A. Franke,et al. Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4 , 2014, Gut.
[8] O. Nielsen,et al. Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation. , 2014, Trends in molecular medicine.
[9] C. Klein,et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[10] M. Seidel. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. , 2014, Blood.
[11] S. Snapper,et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[12] C. Nielsen,et al. Immunodeficiency Associated with a Nonsense Mutation of IKBKB , 2014, Journal of Clinical Immunology.
[13] P. Beales,et al. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease—evaluation and prospective analysis , 2014, Journal of Medical Genetics.
[14] M. Silverberg,et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[15] Yasmine Belkaid,et al. The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.
[16] G. Friedlander,et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. , 2014, Immunity.
[17] C. Klein,et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.
[18] L. Notarangelo,et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. , 2014, The Journal of allergy and clinical immunology.
[19] E. Miele,et al. Phenotype and Disease Course of Early-onset Pediatric Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.
[20] E. Schadt,et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[21] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[22] R. Xavier,et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans , 2014, Proceedings of the National Academy of Sciences.
[23] D. Vozzi,et al. Mevalonate kinase deficiency and IBD: shared genetic background , 2014, Gut.
[24] J. Puchalka,et al. Very Early Onset Inflammatory Bowel Disease Associated with Aberrant Trafficking of IL-10R1 and Cure by T Cell Replete Haploidentical Bone Marrow Transplantation , 2014, Journal of Clinical Immunology.
[25] G. Yılmaz,et al. Colonic Lymphoid Nodular Hyperplasia in Childhood: Causes of Familial Mediterranean Fever Need Extra Attention , 2013, Journal of pediatric gastroenterology and nutrition.
[26] H. Uhlig. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease , 2013, Gut.
[27] K. Schwarz,et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. , 2013, Clinical immunology.
[28] S. Park,et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn's disease and intractable ulcerating enterocolitis. , 2013, European journal of gastroenterology & hepatology.
[29] L. Cuisset,et al. Severe Early-Onset Colitis Revealing Mevalonate Kinase Deficiency , 2013, Pediatrics.
[30] L. Mayer,et al. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[31] D. Miranda-Saavedra,et al. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges , 2013, Briefings in functional genomics.
[32] M. Sperandio,et al. The molecular basis of leukocyte recruitment and its deficiencies. , 2013, Molecular immunology.
[33] P. Saas,et al. Faculty Opinions recommendation of Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. , 2013 .
[34] R. Goldbach-Mansky,et al. Monogenic autoinflammatory diseases: concept and clinical manifestations. , 2013, Clinical immunology.
[35] F. Bushman,et al. Innate lymphoid cells regulate CD4+ T cell responses to intestinal commensal bacteria , 2013, Nature.
[36] T. Kutlu,et al. Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children , 2013, Journal of pediatric gastroenterology and nutrition.
[37] M. Colonna,et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. , 2013, Immunity.
[38] Bodo Grimbacher,et al. B-cell biology and development. , 2013, The Journal of allergy and clinical immunology.
[39] B. Hartmann,et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. , 2013, The Journal of allergy and clinical immunology.
[40] H. Kanegane,et al. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. , 2013, The Journal of allergy and clinical immunology.
[41] C. Buskens,et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues , 2013, Nature Immunology.
[42] R. Locksley,et al. Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.
[43] B. Nadel,et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. , 2012, Blood.
[44] D. Artis,et al. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. , 2012, Immunity.
[45] Y. Belkaid,et al. Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses , 2012, Science.
[46] Casey T. Weaver,et al. Reciprocal interactions of the intestinal microbiota and immune system , 2012, Nature.
[47] S. Snapper,et al. Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice. , 2012, Gastroenterology.
[48] R. Geha,et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. , 2012, The Journal of allergy and clinical immunology.
[49] S. Snapper,et al. The age of gene discovery in very early onset inflammatory bowel disease. , 2012, Gastroenterology.
[50] R. Bacchetta,et al. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..
[51] A. Macpherson,et al. Interactions Between the Microbiota and the Immune System , 2012, Science.
[52] F. Bushman,et al. Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria , 2012, Science.
[53] A. Rizzo,et al. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. , 2012, Arthritis and rheumatism.
[54] F. Alt,et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. , 2012, Blood.
[55] S. Levy,et al. Familial diarrhea syndrome caused by an activating GUCY2C mutation. , 2012, The New England journal of medicine.
[56] Jing Yang,et al. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease , 2012, Genes and Immunity.
[57] A. Rudensky,et al. Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.
[58] M. Eki̇m,et al. An infant with severe refractory Crohn’s disease and homozygous MEFV mutation who dramatically responded to colchicine , 2012, Rheumatology International.
[59] A. Plebani,et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP , 2012, The Journal of experimental medicine.
[60] A. Fischer,et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). , 2012, Blood cells, molecules & diseases.
[61] A. Filipovich. The expanding spectrum of hemophagocytic lymphohistiocytosis , 2011, Current opinion in allergy and clinical immunology.
[62] T. Morio,et al. Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection , 2011, International journal of hematology.
[63] Wei-Li Di,et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. , 2011, The New England journal of medicine.
[64] Judy H. Cho,et al. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 , 2011, Gut.
[65] C. Alpers,et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity , 2011, The Journal of experimental medicine.
[66] D. Wolfsohn,et al. The management of gastrointestinal disease in Hermansky-Pudlak syndrome. , 2011, Journal of clinical gastroenterology.
[67] J. Orange,et al. Congenital alterations of NEMO glutamic acid 223 result in hypohidrotic ectodermal dysplasia and immunodeficiency with normal serum IgG levels. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[68] Fiona Powrie,et al. Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.
[69] S. Travis,et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.
[70] S. Holland,et al. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. , 2011, The Journal of allergy and clinical immunology.
[71] D. Artis,et al. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 , 2011, Nature Immunology.
[72] David P Bick,et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.
[73] Julian Parkhill,et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.
[74] J. Orange,et al. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[76] S. McCartney,et al. Inflammatory bowel diseases in patients with adaptive and complement immunodeficiency disorders. , 2010, Inflammatory bowel diseases.
[77] A. Rudensky,et al. A critical role for regulatory T cell–mediated control of inflammation in the absence of commensal microbiota , 2010, The Journal of experimental medicine.
[78] N. Sebire,et al. Infant colitis—it's in the genes , 2010, The Lancet.
[79] T. Hibi,et al. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. , 2010, Gastroenterology.
[80] P. Schirmacher,et al. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice , 2010, The Journal of experimental medicine.
[81] M. Ziol,et al. The Enteropathy Associated With Common Variable Immunodeficiency: The Delineated Frontiers With Celiac Disease , 2010, The American Journal of Gastroenterology.
[82] A. Macpherson,et al. Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.
[83] J. Scheller,et al. ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by gamma-secretase. , 2010, Biochimica et biophysica acta.
[84] S. Holland,et al. Combined immunodeficiency associated with DOCK8 mutations. , 2009, The New England journal of medicine.
[85] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[86] C. Elson,et al. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota , 2009, Proceedings of the National Academy of Sciences.
[87] S. Tangye,et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production , 2009, Nature Immunology.
[88] Xing Jun Li,et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. , 2009, Blood.
[89] T. To,et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.
[90] J. McCune,et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. , 2009, Clinical immunology.
[91] Janet K. Jansson,et al. Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease , 2009, Inflammatory bowel diseases.
[92] A. Ventura,et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age , 2009, European Journal of Pediatrics.
[93] M. Novelli,et al. Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease , 2009, The American Journal of Gastroenterology.
[94] R. Fässler,et al. Loss of Kindlin-1 Causes Skin Atrophy and Lethal Neonatal Intestinal Epithelial Dysfunction , 2008, PLoS genetics.
[95] U. Pannicke,et al. An immunodeficiency disease with RAG mutations and granulomas. , 2008, The New England journal of medicine.
[96] P. Mcgrogan,et al. Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient‐based registry , 2008, Clinical and experimental immunology.
[97] E. Chi,et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.
[98] S. Rosenzweig. Inflammatory Manifestations in Chronic Granulomatous Disease (CGD) , 2008, Journal of Clinical Immunology.
[99] P. Rufo,et al. Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib , 2008, Journal of Inherited Metabolic Disease.
[100] E. Haan,et al. Chronic colitis due to an epithelial barrier defect: the role of kindlin‐1 isoforms , 2007, The Journal of pathology.
[101] U. Broeckel,et al. Pediatric inflammatory bowel disease: clinical and molecular genetics. , 2007, Inflammatory bowel diseases.
[102] E. Nieuwenhuis,et al. IPEX as a Result of Mutations in FOXP3 , 2007, Clinical & developmental immunology.
[103] H. Ochs,et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. , 2007, The Journal of allergy and clinical immunology.
[104] C. Klein,et al. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. , 2007, Gastroenterology.
[105] D. Hommes,et al. Genetic susceptibility has a more important role in pediatric‐onset Crohn's disease than in adult‐onset Crohn's disease , 2007, Inflammatory bowel diseases.
[106] Martin Wiedmann,et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.
[107] A. Gruber,et al. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.
[108] M. Neurath,et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.
[109] S. Snapper,et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells , 2007, The Journal of experimental medicine.
[110] A. Klausegger,et al. Novel KIND1 gene mutation in Kindler syndrome with severe gastrointestinal tract involvement. , 2006, Archives of dermatology.
[111] O. Goulet,et al. Characteristics of Inflammatory Bowel Disease With Onset During the First Year of Life , 2006, Journal of pediatric gastroenterology and nutrition.
[112] M. van der Burg,et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. , 2006, The New England journal of medicine.
[113] P. Murray. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[114] K. Rajewsky,et al. T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.
[115] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[116] C. Hart,et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.
[117] A. Simon,et al. Effect of CD3δ Deficiency on Maturation of α/β and γ/δ T-Cell Lineages in Severe Combined Immunodeficiency , 2003 .
[118] R. Baldassano,et al. Inflammatory bowel disease in children 5 years of age and younger , 2002, American Journal of Gastroenterology.
[119] D. Roos,et al. Hematologically important mutations: leukocyte adhesion deficiency. , 2001, Blood cells, molecules & diseases.
[120] M. Kronenberg,et al. The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. , 2001, Immunity.
[121] S. Orlow,et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). , 2000, American journal of human genetics.
[122] L. Notarangelo,et al. Diagnostic Criteria for Primary Immunodeficiencies , 1999 .
[123] C. Cunningham-Rundles,et al. Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.
[124] V. Godfrey,et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[125] S. Chanock,et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. , 1998, The Journal of clinical investigation.
[126] Steven F. Ziegler,et al. Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.
[127] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[128] K. Washington,et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. , 1996, The American journal of surgical pathology.
[129] A. Liu,et al. ISOLATION OF A NOVEL GENE MUTATED IN WISKOTT-ALDRICH SYNDROME , 1995, Pediatrics.
[130] C. Ware,et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.
[131] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[132] E. Nice,et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.
[133] David C. Lee,et al. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice , 1993, Cell.
[134] D. Bentley,et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.
[135] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[136] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[137] A. Abo,et al. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 , 1991, Nature.
[138] M. Chang,et al. Wiskott-Aldrich syndrome and inflammatory bowel disease. , 1988, Annals of allergy.
[139] M. Cooper,et al. Primary antibody deficiencies , 1978, Springer Seminars in Immunopathology.
[140] B. Grimbacher,et al. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. , 2014, Current topics in microbiology and immunology.
[141] D. Miranda-Saavedra,et al. The IL-10 / STAT 3-mediated anti-inflammatory response : recent developments and future challenges , 2013 .
[142] Sharon K. Ahluwalia,et al. Peripheral Education of the Immune System by Colonic Commensal Microbiota , 2012 .
[143] Judy H. Cho,et al. Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease , 2012 .
[144] 高山 哲朗. Imbalance of NKp44[+]NKp46[-] and NKp44[-]NKp46[+] natural killer cells in the intestinal mucosa of patients with Crohn's disease , 2011 .
[145] B. Grimbacher,et al. Inflammatory bowel disease: is it a primary immunodeficiency? , 2011, Cellular and Molecular Life Sciences.
[146] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[147] F. Rieux-Laucat,et al. Digestive histopathological presentation of IPEX syndrome , 2009, Modern Pathology.
[148] Y. Hayashi,et al. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan. , 2006, Allergology international : official journal of the Japanese Society of Allergology.
[149] R. Baldassano,et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. , 2005, The Journal of pediatrics.
[150] S. Targan,et al. Bacterial flagellin is a dominant antigen in Crohn disease. , 2004, The Journal of clinical investigation.
[151] R. Blumberg,et al. The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.
[152] K. Zimmer,et al. Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations. , 2002, Gastroenterology.
[153] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[154] L. Notarangelo,et al. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). , 1999, Clinical immunology.
[155] E. Brooks,et al. T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. , 1999, Blood.
[156] D. Vetrie,et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.
[157] R. Geha,et al. Immune deficiencies , infection , and systemic immune disorders T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation , 2022 .